What is BCOR-Rearranged Sarcoma?
BCOR-rearranged sarcoma is a rare type of cancer that develops in soft tissues or sometimes in bones. It occurs due to a specific genetic change involving a gene called BCOR (BCL6 Corepressor). In this condition, the BCOR gene becomes abnormally fused with another gene, leading to uncontrolled growth of cells. This genetic abnormality is what defines the tumour and separates it from other similar sarcomas.
In the past, many of these tumours were misdiagnosed as Ewing sarcoma or other small round cell tumours because they look similar under the microscope. However, modern molecular testing has shown that BCOR-rearranged sarcoma is a distinct and separate disease with its own behavior and characteristics.
Incidence
This cancer is very rare. It most commonly affects children and young adults, although it can appear at any age. The tumour usually develops in the deep soft tissues of the arms, legs, pelvis, or trunk. In some cases, it may arise directly from the bone.
Because it is uncommon and resembles other tumours, specialised genetic testing is required to confirm the diagnosis.
Symptoms
The most common symptom is a slowly enlarging mass or swelling in the affected area. In early stages, it may not cause pain. As the tumour grows, it can lead to discomfort, tenderness, or difficulty moving the nearby limb. If it develops in bone, persistent bone pain may be present.
In advanced stages, if the cancer spreads, general symptoms such as fatigue or weight loss may occur. The lungs are one of the most common sites where this tumour can spread.
Diagnosis
Diagnosis begins with imaging tests such as MRI or CT scans to identify the size and exact location of the tumour. A biopsy is necessary to confirm the disease. Under the microscope, the tumour often appears as small round or spindle-shaped cells.
However, the most important step in diagnosis is molecular testing to detect the BCOR gene rearrangement. Without this genetic confirmation, it may be mistaken for other types of sarcoma.
Additional scans are performed to check whether the cancer has spread to other organs.
Treatment
Treatment usually involves surgery to remove the tumour completely. Because this cancer can behave aggressively, chemotherapy is commonly given before or after surgery. Radiation therapy may also be used in certain cases, especially if complete surgical removal is difficult.
The treatment approach often resembles that used for other aggressive sarcomas.
Prognosis
The outlook depends on several factors, including the size of the tumour, whether it has spread, and how well it responds to treatment. Some patients respond well to therapy, especially when diagnosed early. However, this tumour can recur or spread, so regular follow-up is very important.
Early diagnosis and proper molecular testing play a key role in improving outcomes.
You can help us with your donation:
Without a Ribbon is a charity that works hard to aid those who suffer from rare cancers. You can help our cause in a variety of ways: